Taking a daily supplement with antioxidant vitamins and minerals may slow the progression of late-stage dry age-related macular degeneration and could help maintain central vision in affected patients, according to researchers at NIH.
The original Age-Related Eye Diseases Study (AREDS), published in 2001, found that a supplement formulated with antioxidants — including vitamins C, E and beta-carotene — as well as zinc and copper could slow progression of intermediate to late-stage AMD. More than a decade later, the AREDS2 trial published in 2013 determined that substituting the